Browsing by Author Shepherd, James

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2006Aggressive lipid lowering with atorvastatin reduces increased risk of cardiovascular events in patients with metabolic syndrome and coronary heart diseaseBarter, Philip; Carmena, Rafael; Deedwania, Prakash; Fruchart, Jean-Charles; Haffner, Steven; Shepherd, James; Treating to New Targets, (TNT) Investigators; Central Clinical School: Heart Research InstituteAggressive lipid lowering with atorvastatin reduces increased risk of cardiovascular events in patients with metabolic syndrome and coronary heart disease, European Heart Journal (English Edition), vol.27, Suppl 1,pp 931-932
2002Coronary heart disease in patients with low LDL-cholesterol: Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factorsKeech, Anthony (Tony); Braunwald, Eugene; Craven, Timothy; Furberg, Curt D; Pfeffer, Marc A; Sacks, Frank M; Shepherd, James; Tonkin, Andrew M; School of Public Health: NH&MRC Clinical Trials CentreCoronary heart disease in patients with low LDL-cholesterol: Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors, Circulation (Baltimore), vol.105,(12),2002,pp 1424-1428
2006Effect of intensive cholesterol lowering with atorvastatin in patients with previous coronary bypass surgery: a Treating to New Targets (TNT) substudyBarter, Philip; Kastelein, John J.P.; LaRosa, John C.; Shah, S.; Shepherd, James; Treating to New Targets, (TNT) Investigators; Waters, David D; Wenger, Nanette K.; Central Clinical School: Heart Research InstituteEffect of intensive cholesterol lowering with atorvastatin in patients with previous coronary bypass surgery: a Treating to New Targets (TNT) substudy, European Heart Journal (English Edition), vol.27, Suppl 1,pp 943-N/A
2005Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease.Simes, Robert John; Cobbe, Stuart M; Craven, Timothy; et, al; Furberg, C; Isles, Chris; Pfeffer, M; Sacks, Frank; Shepherd, James; Tonelli, Marcello; Tonkin, Andrew; School of Public Health: NH&MRC Clinical Trials CentreEffect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease., Circulation 2005, vol.112,(2),2005,pp 171-178
2002Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levelsKeech, Anthony (Tony); Simes, Robert John; Braunwald, Eugene; Davis, B R; Ford, I; Furberg, Curt D; Shepherd, James; Tonkin, Andrew M; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels, European Heart Journal, vol.23,(3),2002,pp 207-215
2005Intensive lipid lowering with atorvastatin in patients with stable coronary disease.Barter, Philip; et al, various; Fruchart, Jean-Charles; Gotto, Antonio M.; Greten, Heiner; Grundy, Scott M.; Kastelein, John J.P.; LaRosa, John C.; Shear, Charles; Shepherd, James; Waters, David D; Wenger, Nanette K.; Central Clinical School: MedicineIntensive lipid lowering with atorvastatin in patients with stable coronary disease., New England Journal of Medicine, vol.352,(14),2005,pp 1425-35